Scientific exchange is no longer confined to congress halls or journal pages. Increasingly, it takes place in digital environments — visible, searchable, and open to interpretation and criticism.
For pharmaceutical, biotech and medtech organisations, this shift presents real opportunity. A well-considered pharma social media strategy can strengthen scientific visibility, support healthcare professional (HCP) engagement online and provide valuable real-world insights.
As with all pharma communication, these opportunities must be balanced with regulatory risks. A considered approach is essential: one that recognises both the potential of social media and the standards required to use it effectively.
The opportunity: visibility, engagement and insight
Social media has become a meaningful channel for scientific communication and HCP engagement online. When used well, it allows organisations to:
- support disease awareness initiatives
- identify and challenge misinformation
- share peer-reviewed publications and congress highlights in a non-promotional context
- provide plain-language summaries to improve understanding
- present complex data through infographics and short-form videos
- strengthen corporate scientific reputation
- gather insight through healthcare social listening.
For medical affairs, this enables timely, evidence-based dialogue with healthcare professionals. For commercial teams, it offers visibility and brand presence within appropriate boundaries.
In practice, many organisations now use platforms such as LinkedIn to share congress highlights or visual abstracts, while clinicians and researchers actively discuss new data on X during major scientific meetings. These interactions can extend the lifespan and reach of scientific content well beyond traditional channels.
Social listening also plays an increasingly important role. Monitoring professional discussions, patient communities and therapy-area conversations can highlight emerging questions, sentiment shifts and misinformation trends. These insights can inform future educational materials and refine your broader digital engagement strategy.
As highlighted in recent industry perspectives, social media is increasingly being used to extend the reach of scientific content and congress activity, while supporting more agile and responsive communication approaches.
A complex regulatory environment
While the opportunities are clear, social media fundamentally changes how information is consumed and shared.
Content can be rapidly disseminated beyond its intended audience. Posts may be reshared, reframed or interpreted without the original context. These factors can blur the boundaries between scientific exchange and promotional communication. What may be appropriate in a controlled setting does not always translate directly to an open digital environment.
Awareness of relevant regulations is therefore critical.
Understanding the regulatory landscape
Regulators have made it clear that social media is not exempt from existing standards. Whether the FDA in the US, the PMCPA in the UK or the EFPIA across Europe, digital health communications must meet the same transparency and promotional standards as traditional materials.
Recent updates to regulatory guidance, particularly from the FDA, reinforce expectations around fair balance, risk communication, and accountability in digital channels.
When we consider social media compliance, key risks include:
- off-label drug promotion
- incomplete or unbalanced presentation of safety data
- failure to document approvals and oversight
- inadequate monitoring of comments for reportable adverse events
- third-party interactions creating unintended promotional implications (for example, in most countries, the promotion of medicines to the public is prohibited).
These challenges are not theoretical. Regulatory bodies have issued warning letters linked to social media activity, including posts that omitted risk information or created misleading impressions of efficacy.
Building a robust and compliant approach
To engage effectively on social media, organisations need structured frameworks that support both scientific integrity and regulatory compliance.
Key elements typically include:
- clear governance policies
- defined review and approval workflows across medical, legal and regulatory teams
- established adverse event monitoring and reporting processes
- ongoing audit and oversight mechanisms.
Importantly, digital communication should not be treated as informal or exempt from scrutiny. The same standards that apply to traditional materials must be upheld — often within tighter constraints.
Principles for effective engagement
Successful social media communication balances accessibility with precision.
Consider:
- Clarity: ensure content is accurate, referenced and contextualised
- Transparency: clearly disclose sources, sponsorship and intent, and distinguish scientific exchange from promotional content
- Audience: tailor tone appropriately for HCPs, policymakers or the public
- Platform etiquette: respect the conventions of each platform, including tone, audience and purpose
- Responsiveness: plan how interactions, comments and questions will be managed
- Timing: align content with key milestones such as congresses or publications
- Documentation: maintain records of approvals, update and monitoring activities.
Short-form content still carries long-term reputational impact. Every post reflects your organisation’s scientific integrity.
Turning opportunity into confidence
Social media is now an integral part of medical communication. Its value lies not only in reach, but in its ability to support timely, relevant and engaging scientific exchange.
Organisations that use these channels effectively tend to combine:
- strategic, audience-appropriate content
- active healthcare social listening
- strong cross-functional alignment
- clearly defined governance and compliance processes.
Social media is here to stay. The question is not whether to engage — but how to do so responsibly and effectively.
At Elion, we support life sciences teams in translating complex science into clear, compelling digital content that performs across platforms, without compromising compliance. From writing or adapting disease awareness content for social media to developing plain-language summaries and infographics, we help organisations engage confidently while protecting credibility.
Looking to elevate your medical or corporate content for social media?
Contact us so we can work together to make an impact while staying compliant.
Photo credit: Image courtesy of Freepik
